PAM
ALXN

PartnerRe Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

PartnerRe Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,515
Closed -$211K – 443
2016
Q1 		$211K Hold
1,515
– – 0.11% 145
2015
Q4 		$289K Sell
1,515
-2,578
-63% -$450K 0.15% 106
2015
Q3 		$640K Buy
4,093
+49
+1% +$8.94K 0.11% 134
2015
Q2 		$731K Sell
4,044
-239
-6% -$41.2K 0.14% 129
2015
Q1 		$742K Buy
4,283
+60
+1% +$10.9K 0.12% 142
2014
Q4 		$781K Buy
4,223
+602
+17% +$112K 0.13% 138
2014
Q3 		$600K Sell
3,621
-585
-14% -$96.1K 0.12% 149
2014
Q2 		$657K Sell
4,206
-575
-12% -$90.8K 0.12% 162
2014
Q1 		$727K Buy
4,781
+61
+1% +$9.7K 0.12% 158
2013
Q4 		$627K Sell
4,720
-264
-5% -$31.7K 0.11% 171
2013
Q3 		$579K Sell
4,984
-647
-11% -$71K 0.1% 181
2013
Q2 		$519K Buy
+5,631
New +$543K 0.08% 211

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return